Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
1993 | 1 |
2010 | 1 |
2017 | 1 |
2018 | 1 |
2023 | 2 |
2024 | 0 |
Search Results
6 results
Results by year
Filters applied: . Clear all
It looks like you are searching for an author.
Results are currently sorted by Best Match. To see the newest results first,
change the sort order to Most Recent.
Page 1
Bezlotoxumab for Prevention of Recurrent Clostridium difficile Infection.
N Engl J Med. 2017 Jan 26;376(4):305-317. doi: 10.1056/NEJMoa1602615.
N Engl J Med. 2017.
PMID: 28121498
Free article.
Clinical Trial.
Efficacy and safety of gluten peptide-based antigen-specific immunotherapy (Nexvax2) in adults with coeliac disease after bolus exposure to gluten (RESET CeD): an interim analysis of a terminated randomised, double-blind, placebo-controlled phase 2 study.
Tye-Din JA, Daveson AJM, Goel G, Goldstein KE, Hand HL, Neff KM, Popp A, Taavela J, Maki M, Isola J, Williams LJ, Truitt KE, Anderson RP; RESET CeD Study Group.
Tye-Din JA, et al.
Lancet Gastroenterol Hepatol. 2023 May;8(5):446-457. doi: 10.1016/S2468-1253(22)00428-9. Epub 2023 Mar 7.
Lancet Gastroenterol Hepatol. 2023.
PMID: 36898393
Clinical Trial.
Item in Clipboard
Long-term safety of tenapanor in patients with irritable bowel syndrome with constipation in the T3MPO-3 study.
Lembo AJ, Friedenberg KA, Fogel RP, Edelstein S, Zhao S, Yang Y, Rosenbaum DP, Chey WD.
Lembo AJ, et al. Among authors: friedenberg ka.
Neurogastroenterol Motil. 2023 Nov;35(11):e14658. doi: 10.1111/nmo.14658. Epub 2023 Sep 5.
Neurogastroenterol Motil. 2023.
PMID: 37668173
Item in Clipboard
A Phase 2, Randomized, Placebo-Controlled Study Evaluating Matrix Metalloproteinase-9 Inhibitor, Andecaliximab, in Patients With Moderately to Severely Active Crohn's Disease.
Schreiber S, Siegel CA, Friedenberg KA, Younes ZH, Seidler U, Bhandari BR, Wang K, Wendt E, McKevitt M, Zhao S, Sundy JS, Lee SD, Loftus EV.
Schreiber S, et al. Among authors: friedenberg ka.
J Crohns Colitis. 2018 Aug 29;12(9):1014-1020. doi: 10.1093/ecco-jcc/jjy070.
J Crohns Colitis. 2018.
PMID: 29846530
Free PMC article.
Clinical Trial.
Item in Clipboard
Once-daily dosing of delayed-release oral mesalamine (400-mg tablet) is as effective as twice-daily dosing for maintenance of remission of ulcerative colitis.
Sandborn WJ, Korzenik J, Lashner B, Leighton JA, Mahadevan U, Marion JF, Safdi M, Sninsky CA, Patel RM, Friedenberg KA, Dunnmon P, Ramsey D, Kane S.
Sandborn WJ, et al. Among authors: friedenberg ka.
Gastroenterology. 2010 Apr;138(4):1286-96, 1296.e1-3. doi: 10.1053/j.gastro.2009.12.054. Epub 2010 Jan 11.
Gastroenterology. 2010.
PMID: 20064514
Clinical Trial.
Item in Clipboard
Intestinal perforation due to Mycobacterium tuberculosis in HIV-infected individuals: report of two cases.
Friedenberg KA, Draguesku JO, Kiyabu M, Valenzuela JE.
Friedenberg KA, et al.
Am J Gastroenterol. 1993 Apr;88(4):604-7.
Am J Gastroenterol. 1993.
PMID: 8470647
Item in Clipboard
Cite
Cite